Lttl review
A deep compounded menu — injectable, oral tablet and microdose — with a full public price matrix, and four pharmacies named in the Terms rather than on any product page.
Pricing last checked on Lttl's own site .
- Semaglutide
- $199/mo injectable month-to-month, $169/mo on 3 months, $149/mo on 6 months, $129/mo on a 12-mo prepay
- Tirzepatide
- $279/mo injectable month-to-month, $249/mo on 3 months, $229/mo on 6 months, $199/mo on a 12-mo prepay
- Coverage
- Multi-state
- Brand-name
- Compounded only
The scorecard
Lttl scored on our six published factors. See the methodology.
What we like
- The /plans page carries every product against all five tiers — monthly, 3-, 6- and 12-month and a first-month special — so the real month-to-month rate is public
- Price is flat at every dose, so moving up a dose does not raise the monthly bill
- States plainly that its compounded GLP-1s 'are not FDA-approved and have not been evaluated by the FDA for safety, efficacy, or quality'
- Offers an oral dissolving-tablet semaglutide at $229/mo month-to-month for people who want to avoid injections
- Runs a microdose line — low-dose semaglutide or tirzepatide at $149/mo month-to-month — for people sensitive to side effects
The caveats
- Compounded only, and compounded GLP-1s are not FDA-approved; no brand-name Wegovy, Zepbound, Ozempic or Mounjaro
- Four partner pharmacies are named in section 11 of the Terms — RedRock Pharmacy (St. George, UT), Health Warehouse (Florence, KY), Precision Compounding Pharmacy (Bellmore, NY) and Triad Rx (Daphne, AL), each with a website, address and phone — but nowhere a buyer is looking, and the identical block appears on Taurus Meds, Remevi, Embody and Nolu — so it reads as a shared platform bench rather than a Lttl-specific supply chain
- The marketed 'Plans start at $129/mo' is the twelve-month prepay rate; month-to-month is $199 semaglutide and $279 tirzepatide
- No public list of states served; eligibility depends on where unnamed partner providers happen to be licensed
- Medication cannot be returned or refunded once it ships, the terms impose individual arbitration with a class-action waiver, and support is email and portal only with no phone line
The verdict
Best for: Shoppers comparing commitment lengths who want the true month-to-month rate visible, or who want an oral or low-dose option instead of a standard injection. A deep compounded menu — injectable, oral tablet and microdose — with a full public price matrix, and four pharmacies named in the Terms rather than on any product page.
Ranked #303 of 539 providers we have reviewed — for comparison, read the CoreAge Rx review, our #1 pick. In the ranking it sits between Aquivia Health at #302, 64/100 above and MyStart Health at #304, 63/100 below, with the Fresh Day Meds ruling the next one down.
Lttl is one of 539 rulings in this ranking, which makes the fair next question who sits above it — our shortlist of Lttl alternatives answers it in order, with every score shown.For the wider picture, every ruling we have published ranks the field on the same six factors. We have also ruled on it directly: CoreAge Rx vs Lttl goes to CoreAge Rx, 94/100 to 61/100.
Compare with other providers
The closest rulings to Lttl by Verdict Score — the realistic shortlist if you are weighing this one up.
- #317Primary Clinic— Primary Clinic (Direct GLP) is a Direct Primary Care membership rather than the usual direct-to-consumer GLP-1 marketplace.63/100
- #318RxSaludable— RxSaludable is a Spanish-language GLP-1 weight-loss telehealth service (atencion en espanol) offering compounded semaglutide from $99 the first month ($179/mo after) and tirzepatide from $189 the first…63/100
- #319Wisp— Wisp (hellowisp.com) is a US telehealth provider whose weight care vertical offers brand-name Wegovy, Zepbound, and Saxenda alongside a compounded sublingual semaglutide drops formulation at $225/month.63/100
- #320HumeCare+— HumeCare+ is the GLP-1 telehealth program from Hume Health, the body-composition scale company.60/100
- #321Mint Med— A flat $159 across every dose of either GLP-1 with no membership, carrying an FDA warning letter from June 2026.62/100
- #322Alinwell— Publishes its pharmacies' certificates of analysis and then advertises a first-month price as if it were the rate.62/100
Pricing, states and verification reflect Lttl's public disclosures at last review; the Verdict Score is our editorial judgment per the methodology. Prices change — confirm on Lttl's site. Not medical advice; see our disclosure.